Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Covid-19 Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04811339
What this trial is testing

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)

Who this might be right for
DiarrheaCOVID-19
University of Cincinnati 60
Not applicableNo Longer AvailableNCT06004128
What this trial is testing

Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments

Who this might be right for
COVID-19
Invivyd, Inc.
Not applicableStudy completedNCT04395430
What this trial is testing

A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19

Who this might be right for
Pediatric ObesityClinical Trial
KK Women's and Children's Hospital 40
Not applicableUnknownNCT04878796
What this trial is testing

Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV)

Who this might be right for
CancerCovid-19Vaccine Response
Azienda Socio Sanitaria Territoriale di Cremona 300
Not applicableStudy completedNCT05501288
What this trial is testing

Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019

Who this might be right for
Coronavirus Disease 2019
Shanghai Children's Medical Center 108
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Not applicableStudy completedNCT04453475
What this trial is testing

Feasibility and Benefits of Digital Services During the COVID19 Pandemic

Who this might be right for
Psychosomatic DisorderPsychological DistressPsychological Stress+12 more
Jacobs University Bremen gGmbH 2,000
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07406217
What this trial is testing

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

Who this might be right for
COVID-19Immunodeficiency
Calmy Alexandra 256
Not applicableStudy completedNCT04873349
What this trial is testing

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

Who this might be right for
Covid19COVID-19 Respiratory InfectionSymptoms and Signs+2 more
Shimaa M. Abdelgawad 60
Early research (Phase 1)Ended earlyNCT05027815
What this trial is testing

Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)

Who this might be right for
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Jeffrey Bluestone 7
Not applicableUnknownNCT04522037
What this trial is testing

Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients

Who this might be right for
Patients Hospitalized in the Hospices Civils of LyonCOVID-19 DiseaseModerate to Severe Dyspnea+1 more
Hospices Civils de Lyon 200
Early research (Phase 1)Study completedNCT04507256
What this trial is testing

AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19

Who this might be right for
COVID-19
AstraZeneca 60
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Not applicableUnknownNCT05227560
What this trial is testing

The Effect of the Emotional Freedom Technique on Students

Who this might be right for
Coping SkillsAnxietyComplementary Therapies+1 more
Zonguldak Bulent Ecevit University 80
Testing effectiveness (Phase 2)Ended earlyNCT05122182
What this trial is testing

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
University of Sydney 49
Early research (Phase 1)WithdrawnNCT04371640
What this trial is testing

Sirolimus in COVID-19 Phase 1

Who this might be right for
SARS-CoV-2Covid-19
Walter K. Kraft
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Not applicableUnknownNCT04624997
What this trial is testing

Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection

Who this might be right for
COVID-19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 1,000
Next Page